Methylbenzethonium

Methylbenzethonium

SCHEMBL29630503

Cc1cc(C(C)(C)CC(C)(C)C)ccc1OCCOCC[N+](C)(C)Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 1.00
TSHR P16473 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
CYP2D6 P10635 3/20 1.00
CYP1A2 P05177 1/20 1.00
SMN1; SMN2 Q16637 6/20 0.98
MEN1 O00255 5/20 0.98
KMT2A Q03164 5/20 0.98
ALDH1A1 P00352 4/20 0.98
USP2 O75604 4/20 0.98
TP53 P04637 4/20 0.98
APAF1 O14727 3/20 0.98
MAPT P10636 3/20 0.98
RAD52 P43351 3/20 0.98
HSP90AA1 P07900 1/20 0.98
UBE2N P61088 1/20 0.98
CYP3A4 P08684 4/20 0.72
HIF1A Q16665 3/20 0.72
ERBB2 P04626 2/20 0.72
FYN P06241 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylbenzethonium SCHEMBL790480 1.00 LMNA (1.00) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL4418242 0.99 LMNA (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL7065208 0.99 LMNA (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL4413366 0.99 LMNA (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL136062 0.99 SMN1; SMN2 (1.00) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL29740116 0.98 SMN1; SMN2 (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Methylbenzethonium SCHEMBL10984834 0.98 SMN1; SMN2 (0.98) LMNATSHRTDP1CYP2D6CYP1A2
Hydrochloric Acid SCHEMBL11425941 0.92 SMN1; SMN2 (0.86) LMNATSHRTDP1CYP2D6CYP1A2
SCHEMBL14234861 0.90 LMNA (0.82) LMNATSHRTDP1CYP2D6CYP1A2
Benzethonium SCHEMBL122985 0.84 SMN1; SMN2 (1.00) LMNATSHRTDP1CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010443-A1 COMPOSITIONS FOR TUNGSTEN ETCHING INHIBITION BASF SE (DE) 2022-06-15 EP claimed
US-20240307414-A1 METHODS AND MATERIALS FOR TREATING PROSTATE CANCER MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2024-09-19 US disclosed
WO-2024168218-A1 WEARABLE ELECTROPHYSIOLOGICAL MONITORING SYSTEMS THE UNIVERSITY OF MASSACHUSETTS (US) 2024-08-15 WO disclosed
US-20220267643-A1 COMPOSITIONS FOR TUNGSTEN ETCHING INHIBITION BASF SE (DE) 2022-08-25 US disclosed
WO-2022094685-A1 COMPOSITION, PHARMACEUTICAL COMPOSITION, USE OF A STABLE TOPICAL COMPOSITION COMPRISING A NANOEMULSION AND OF AT LEAST ONE ANTILEISHMANIAL COMPOUND, AND METHOD FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS FUNDAÇÃO OSWALDO CRUZ (BR) 2022-05-12 WO disclosed